WASHINGTON - The National Institutes of Health has halted its study of hydroxychloroquine, concluding the drug President Donald Trump widely touted after a panel of experts concluded it was unlikely to help hospitalized coronavirus patients. Many scientists and public health specialists are worried the whiplash of to-and-fro studies will add static and distraction for a beleaguered public.
View article HERE.